Journal Information
Vol. 93. Issue 3.
Pages 465-466 (1 May 2018)
Share
Share
Download PDF
More article options
Vol. 93. Issue 3.
Pages 465-466 (1 May 2018)
Open Access
Tinea capitis: correlation of clinical presentations to agents identified in mycological culture*
Visits
5658
John Verrinder Veasey1, Guilherme de Souza Cabral Muzy2
1 Sector of Infectious Dermatoses, Dermatology Clinic, Santa Casa de São Paulo, São Paulo (SP), Brazil.
2 Clínica Muzy. São Paulo (SP), Brazil.
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Correlation between the clinical presentation and the agents isolated in fungal cultures
Full Text

Dear Editor,

Tinea capitis (scalp tinea) is a fungal infection of the skin and scalp hairs by dermatophyte fungi. These keratinophilic fungi have an ecologic predilection regarding their adaptation to the environment and can be divided into three large groups according to their habitat: geophilic, zoophilic and anthropophilic.1 Geophilic fungi have Microsporum gypseum as their representative, and zoophilic fungi have Microsporum canis and Trichophyton mentagrophytes var. mentagrophytes.2 These two fungal groups are considered “not adapted to human beings”. The “adapted” fungi are at the top of the fungal phylogenetic scale evolution: they are dermatophytes capable of being a parasite to humans, known as anthropophilic fungi. Examples of this group are Epidermophyton floccosum, Trichophyton tonsurans, Trichophyton schoenleinii, Trichophyton mentagrophytes var. interdigitalis and Trichophyton rubrum.1,2

The clinical manifestations of tinea capitis can be divided into alopecic and inflammatory.1 Alopecic tineas are represented by areas of alopecia, usually round-shaped and with variable itch, where hairs are fragmented, resulting in an aspect similar to tonsure – a close shave at the vertex of the scalp similar to some monks. They can be further divided into two patterns: microsporosis, where the clinical lesions are few in number, can reach large diameters and are typically associated to the dermatophytes from the genus Microsporum sp, and the trichophytosis, where the alopecic lesions are multiple and small, many times difficult to identify, and classically related to agents from the genus Trichophyton sp (Figure 1).1–3

Figure 1.

Tinea capitis clinical forms: alopecic microsporosis (A1 and A2); alopecic trichophytosis (B1 and B2); andkerion Celsi (C1 and C2) – arrow indicating reactional lymph node enlargement, typical of this presentation. Fungal culture of the main isolated agents: Microsporum canis macroculture showing white, cottony colonies with a bright-yellow reverse (D1) and microculture with hyaline septate hyphae and spindle-shaped macroconidia with more than 6 septa inside them (D2); Trichophyton tonsurans macroculture with powdery, brownish and cerebriform colonies (E1) and microculture with hyaline septate hyphae and interspersed microconidia (E2)

(0.9MB).

Inflammatory tinea capitis can be further divided into suppurative (or kerion Celsi) and favus. In kerion Celsi, the clinical presentation is of a scaly plaque and intense local inflammatory process with edema, rubor and purulent discharge, evolving many times to cicatricial alopecia (Figure 1).1,2 The agents commonly isolated in these cases are non-adapted dermatophytes, what explains the intense inflammatory reaction by the host. Favus is characterized by masses resembling yellow, concave crusts (scutula or godet), with a central hair, with a rat urine smell. The etiologic agent most commonly associated to this presentation is T. schoenleinii.1,2

We performed a retrospective study in the outpatient clinic of mycology at the service of Dermatology, São Paulo, and analyzed all cases suspicious for tinea capitis seen from January 2013 to June 2017 and correlated their clinical aspects to the agents isolated in the fungal culture. Ninety-four patients were seen during this time, and 37 were excluded because no agent was isolated in the culture, resulting in 57 cases analyzed. The findings are shown in table 1.

Table 1.

Correlation between the clinical presentation and the agents isolated in fungal cultures

CLINICAL PRESENTATIONM. canis  M. gypseum  T. tonsurans  T. mentagrophytes  TOTAL 
AlopecicMicrosprosis  19  28 
Trichophytosis  11  20 
Inflammatory  Kerion celsi  9 
TOTAL30  1  26  1  57 

The results are in accordance to data published in other articles. The main agent isolated in the geographical area of this study was M. canis (52.63%), followed by T. tonsurans (45.61%), M. gypseum and T. mentagrophytes, with only one case each in the period of the study (1.75% each).3,4 The most common clinical presentation was the alopecic microsporosis in 28 cases (49.12%), followed by the alopecic trichophytosis in 20 cases (35.08%), and by kerion Celsi in nine cases (15.78%). No cases of favus were seen, nor was T. schoenleinii isolated, confirming it is a rare presentation in our community.

Despite the fact that anthropophilic fungi are typically related to the trichophytosis pattern and the non-adapted fungi to the microsporosis and kerion Celsi pattern,4 in this study we observed a 45% rate of trichophytosis cases by M. canis, besides 32.14% microsporosis cases caused by T. tonsurans. These data can be interpreted based in the immunological response that each patient presents to the fungus, some with intense response even to anthropophilic fungi and others with a less intense response to non-adapted fungi.5 Another surprising finding that can support this argument was the 66% rate of kerion Celsi cases related to T. tonsurans, anthropophilic fungus that is rarely isolated in this presentation.

Statistical treatment of the data by Fisher’s exact test showed the independence of the etiologic agents regarding the clinical forms with a confidence level of 0.95. therefore, we can conclude that the clinical evaluation of the lesions shows 95% confidence, an invalid procedure to infer the etiological agent, what supports the indication for culture.

Tinea capitis treatment is more well defined according to the etiological agent isolated: terbinafine for Trichophyton sp fungi and griseofulvin for the genus Microsporum sp,1,3 even though griseofulvin can be indicated for Trichophyton sp cases, as long as the use of the medication is extended. The findings of this study show that the mycological analysis through isolation of the agent in fungal cultures is still necessary, since the clinical aspects of tinea capitis might not be related to the expected agents in a large number of cases.

The authors would like to thank Juliane Damasceno for the support with the statistical procedures.

Financial support: None.

Conflict of interests: None.

References
[1.]
J.V. Veasey, BAF Miguel, SAS Mayor, C. Zaitz, L.H. Muramatu, J.A. Serrano.
Epidemiological profile of tinea capitis in São Paulo City.
An Bras Dermatol, 92 (2017), pp. 283-284
[2.]
C. Zaitz, S.A. Marques, L.RB. Ruiz, VMS Framil.
Compêndio de Micologia Médica. 2. ed.
Rio de Janeiro: Guanabara Koogan, (2010), pp. 157-159.
[3.]
A.K. Gupta, C. Drummond-Main.
Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.
Pediatr Dermatol, 30 (2013), pp. 1-6
[4.]
R. Aly.
Ecology and epidemiology of dermatophyte infections.
J Am Acad Dermatol, 31 (1994), pp. S21-S25
[5.]
A. Kallel, A. Hdider, N. Fakhfakh, S. Belhadj, N Belhadj-Salah, N. Bada.
Tinea capitis: Main mycosis child. Epidemiological study on 10 years.
J Mycol Med, 27 (2017), pp. 345-350

Work conducted at Dermatology Clinic, Santa Casa de São Paulo, São Paulo (SP), Brazil.

Copyright © 2018. Anais Brasileiros de Dermatologia
Download PDF
Idiomas
Anais Brasileiros de Dermatologia
Article options
Tools
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.